Ifosfamide-induced nephrotoxicity in oncological patients
- 1 December 2023
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 24 (1-2) , 5-14
Abstract
Ifosfamide is an alkylating chemotherapeutic agent used in the treatment of various neoplasms. Its main adverse effects include renal damage. A comprehensive review was conducted, including 100 articles from the Scielo, Scopus, and EMBASE databases. Ifosfamide-induced nephrotoxicity is attributed to its toxic metabolites, such as acrolein and chloroacetaldehyde, which cause mitochondrial damage and oxidative stress in renal tubular cells. Literature review found a 29-year average age with no gender predominance and a mortality of 13%. Currently, no fully effective strategy exists for preventing ifosfamide-induced nephrotoxicity; however, hydration, forced diuresis, and other interventions are employed to limit renal damage. Long-term renal function monitoring is essential for patients treated with ifosfamide. Ifosfamide remains essential in neoplasm treatment, but nephrotoxicity, often compounded by coadministered drugs, poses diagnostic challenges. Preventive strategies are lacking, necessitating further research. Identifying timely risk factors can mitigate renal damage, and a multidisciplinary approach manages established nephrotoxicity. Emerging therapies may reduce ifosfamide induced nephrotoxicity.Keywords
This publication has 92 references indexed in Scilit:
- Proximal renal tubular acidosis: a not so rare disorder of multiple etiologiesNephrology Dialysis Transplantation, 2012
- Reversible Proximal Renal Tubular Dysfunction after One-Time Ifosfamide ExposureCancer Research and Treatment, 2010
- Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in ChildrenJournal of Clinical Oncology, 2009
- Children's toxicology from bench to bed - Drug-induced Renal Injury (2): Nephrotoxiciy induced by cisplatin and ifosfamide in childrenThe Journal of Toxicological Sciences, 2009
- N‐Acetylcysteine prevents ifosfamide‐induced nephrotoxicity in ratsBritish Journal of Pharmacology, 2008
- Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cellsPediatric Nephrology, 2005
- Bladder cancerCurrent Opinion in Oncology, 2002
- Young age and the risk for ifosfamide-induced nephrotoxicity: a critical review of two opposing studiesPediatric Nephrology, 2001
- Clinical Pharmacokinetics and Pharmacodynamics of Ifosfamide and its MetabolitesClinical Pharmacokinetics, 2001
- Cardiotoxicity of Chemotherapeutic AgentsDrug Safety, 2000